912 related articles for article (PubMed ID: 28271031)
1. Enteroendocrine-derived glucagon-like peptide-2 controls intestinal amino acid transport.
Lee J; Koehler J; Yusta B; Bahrami J; Matthews D; Rafii M; Pencharz PB; Drucker DJ
Mol Metab; 2017 Mar; 6(3):245-255. PubMed ID: 28271031
[TBL] [Abstract][Full Text] [Related]
2. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway.
Yusta B; Matthews D; Flock GB; Ussher JR; Lavoie B; Mawe GM; Drucker DJ
Mol Metab; 2017 Jun; 6(6):503-511. PubMed ID: 28580281
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
[TBL] [Abstract][Full Text] [Related]
5. Role of glial cell-line derived neurotropic factor family receptor alpha2 in the actions of the glucagon-like peptides on the murine intestine.
McDonagh SC; Lee J; Izzo A; Brubaker PL
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G461-8. PubMed ID: 17585017
[TBL] [Abstract][Full Text] [Related]
6. Characterization of glucagon-like peptide 2 pathway member expression in bovine gastrointestinal tract.
Connor EE; Baldwin RL; Capuco AV; Evock-Clover CM; Ellis SE; Sciabica KS
J Dairy Sci; 2010 Nov; 93(11):5167-78. PubMed ID: 20965332
[TBL] [Abstract][Full Text] [Related]
7. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
8. Intestinotrophic glucagon-like peptide-2 (GLP-2) activates intestinal gene expression and growth factor-dependent pathways independent of the vasoactive intestinal peptide gene in mice.
Yusta B; Holland D; Waschek JA; Drucker DJ
Endocrinology; 2012 Jun; 153(6):2623-32. PubMed ID: 22535770
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.
Hsieh J; Longuet C; Maida A; Bahrami J; Xu E; Baker CL; Brubaker PL; Drucker DJ; Adeli K
Gastroenterology; 2009 Sep; 137(3):997-1005, 1005.e1-4. PubMed ID: 19482026
[TBL] [Abstract][Full Text] [Related]
10. Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells.
Koehler JA; Harper W; Barnard M; Yusta B; Drucker DJ
Cancer Res; 2008 Oct; 68(19):7897-904. PubMed ID: 18829546
[TBL] [Abstract][Full Text] [Related]
11. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2.
Drucker DJ; Yusta B
Annu Rev Physiol; 2014; 76():561-83. PubMed ID: 24161075
[TBL] [Abstract][Full Text] [Related]
12. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine.
Lovshin J; Yusta B; Iliopoulos I; Migirdicyan A; Dableh L; Brubaker PL; Drucker DJ
Endocrinology; 2000 Nov; 141(11):4194-201. PubMed ID: 11089553
[TBL] [Abstract][Full Text] [Related]
13. T1R2 receptor-mediated glucose sensing in the upper intestine potentiates glucose absorption through activation of local regulatory pathways.
Smith K; Karimian Azari E; LaMoia TE; Hussain T; Vargova V; Karolyi K; Veldhuis PP; Arnoletti JP; de la Fuente SG; Pratley RE; Osborne TF; Kyriazis GA
Mol Metab; 2018 Nov; 17():98-111. PubMed ID: 30201274
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological activation of TGR5 promotes intestinal growth via a GLP-2-dependent pathway in mice.
Hunt JE; Billeschou A; Windeløv JA; Hartmann B; Ullmer C; Holst JJ; Kissow H
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G980-G987. PubMed ID: 32308039
[TBL] [Abstract][Full Text] [Related]
15. Intestine-selective reduction of Gcg expression reveals the importance of the distal gut for GLP-1 secretion.
Panaro BL; Yusta B; Matthews D; Koehler JA; Song Y; Sandoval DA; Drucker DJ
Mol Metab; 2020 Jul; 37():100990. PubMed ID: 32278655
[TBL] [Abstract][Full Text] [Related]
16. ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel.
Bahrami J; Yusta B; Drucker DJ
Gastroenterology; 2010 Jun; 138(7):2447-56. PubMed ID: 20226187
[TBL] [Abstract][Full Text] [Related]
17. Loss of Glp2r signaling activates hepatic stellate cells and exacerbates diet-induced steatohepatitis in mice.
Fuchs S; Yusta B; Baggio LL; Varin EM; Matthews D; Drucker DJ
JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32191643
[TBL] [Abstract][Full Text] [Related]
18. Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.
Liu X; Murali SG; Holst JJ; Ney DM
Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1794-802. PubMed ID: 18832087
[TBL] [Abstract][Full Text] [Related]
19. Disruption of the murine Glp2r impairs Paneth cell function and increases susceptibility to small bowel enteritis.
Lee SJ; Lee J; Li KK; Holland D; Maughan H; Guttman DS; Yusta B; Drucker DJ
Endocrinology; 2012 Mar; 153(3):1141-51. PubMed ID: 22253424
[TBL] [Abstract][Full Text] [Related]
20. The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis.
Guan X
Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R585-96. PubMed ID: 24990862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
